Cannabidiol (CBD) Acts as an Antioxidant on Gardnerella vaginalis, Resulting in Reduced Metabolic Activity, Loss of Survivability, and Elimination of Biofilms
Antibiotics,
Journal Year:
2025,
Volume and Issue:
14(2), P. 136 - 136
Published: Feb. 1, 2025
Background:
Gardnerella
vaginalis
is
a
natural
inhabitant
of
the
vagina,
but
when
an
imbalance
occurs
in
vaginal
microbiota,
this
bacterium
can
cause
vaginosis,
condition
that
must
be
treated
symptomatic
and
prior
to
gynecological
intervention.
Cannabidiol
(CBD)
anti-inflammatory
compound
also
has
antibacterial
activities
against
several
Gram-positive
certain
Gram-negative
bacteria.
Objectives:
Since
G.
opportunistic
pathogenic
Gram-variable
bacterium,
we
investigated
its
response
CBD.
Methods:
The
activity
CBD
was
studied
by
broth
dilution
assay,
changes
intracellular
ATP
levels,
ability
bacteria
recover
on
chocolate
agar
plates.
antibiofilm
MTT
metabolic
crystal
violet
staining,
HR-SEM.
Flow
cytometric
analyses
were
performed
measure
membrane
potential,
perforation,
activity.
Reactive
oxygen
species
(ROS)
production
analyzed
using
nitro
blue
tetrazolium
(NBT)
reagent.
Gene
expression
determined
semi-quantitative
real-time
PCR,
while
protein
composition
LC-MS/MS
analysis.
Results:
We
observed
clinical
isolates
exhibited
high
susceptibility
with
minimum
inhibitory
concentration
(MIC)
2.5
µg/mL
induced
rapid
hyperpolarization
caused
cytoplasmic
leakage
without
increasing
propidium
iodide
uptake.
This
accompanied
reduced
loss
survivability.
Proteomic
analysis
revealed
decreased
some
ribosomal-associated
proteins.
antioxidant
reducing
ROS
levels
dose-dependent
manner.
effect
neutralized
free
radical
scavenger
α-tocopherol,
suggesting
involvement
radicals
executing
effect.
Importantly,
not
only
prevented
biofilm
formation
biomass
preformed,
mature
biofilms.
Real-time
PCR
for
6
h
showed
increase
biofilm-associated
genes,
mainly
due
did
alter
adhere
HeLa
cervical
carcinoma
cells
CBD-treated
still
phagocytosed
RAW264.7
macrophages.
Conclusions:
Our
study
shows
exhibits
thus
potential
drug
treatment
vaginosis
bacterium.
Language: Английский
Surface-enhanced Raman scattering for the detection of biomarkers of neurodegenerative diseases: A review
Chentao Li,
No information about this author
Yinglin Wang,
No information about this author
Yafang Wu
No information about this author
et al.
TrAC Trends in Analytical Chemistry,
Journal Year:
2025,
Volume and Issue:
185, P. 118173 - 118173
Published: Feb. 3, 2025
Language: Английский
A predictive machine learning model for cannabinoid effect based on image detection of reactive oxygen species in microglia
Patricia Sinclair,
No information about this author
William Jeffries,
No information about this author
Nadege Lebert
No information about this author
et al.
PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(3), P. e0320219 - e0320219
Published: March 25, 2025
Neuroinflammation
is
a
key
feature
of
human
neurodisease
including
neuropathy
and
neurodegenerative
disease
driven
by
the
activation
microglia,
immune
cells
nervous
system.
During
microglia
release
pro-inflammatory
cytokines
as
well
reactive
oxygen
species
(ROS)
that
can
drive
local
neuronal
glial
damage.
Phytocannabinoids
are
an
important
class
naturally
occurring
compounds
found
in
cannabis
plant
(
Cannabis
sativa
)
interact
with
body’s
endocannabinoid
receptor
Cannabidiol
(CBD)
prototype
phytocannabinoid
anti-inflammatory
properties
observed
animal
models.
We
measured
ROS
(HMC3)
using
CellROX,
fluorescent
dynamic
indicator.
tested
effect
CBD
on
level
presence
three
known
activators:
lipopolysaccharide
(LPS),
amyloid
beta
(A
β
42
),
immunodeficiency
virus
(HIV)
glycoprotein
(GP120).
Confocal
microscopy
images
within
were
coupled
to
deep
learning
model
convolutional
neural
network
(CNN)
predict
responses.
Our
study
demonstrates
platform
be
used
assessment
image
measure.
Language: Английский
Cannabis for medicine and food: A benefit vs risk critical appraisal
Murendeni Nethengwe,
No information about this author
Y Maphosa,
No information about this author
BO Ahiante
No information about this author
et al.
South African Journal of Botany,
Journal Year:
2024,
Volume and Issue:
175, P. 15 - 31
Published: Oct. 11, 2024
Language: Английский
Bioactive Three-Dimensional Chitosan-Based Scaffolds Modified with Poly(dopamine)/CBD@Pt/Au/PVP Nanoparticles as Potential NGCs Applicable in Nervous Tissue Regeneration—Preparation and Characterization
Molecules,
Journal Year:
2024,
Volume and Issue:
29(22), P. 5376 - 5376
Published: Nov. 14, 2024
Tissue
engineering
of
nervous
tissue
is
a
promising
direction
in
the
treatment
neurological
diseases
such
as
spinal
cord
injuries
or
neuropathies.
Thanks
to
technological
progress
and
scientific
achievements;
use
cells;
artificial
scaffolds;
growth
factors
are
becoming
increasingly
common.
Despite
challenges
complex
structure
this
tissue,
regenerative
medicine
appears
future
approach
improve
quality
life
patients
with
injuries.
Until
now;
most
functional
biomaterials
used
for
purpose
were
based
on
decellularized
extra
cellular
matrix
(ECM)
nanofibrous
materials,
whereas
current
clinically
verified
ones
cases
do
not
exhibit
bioactivity
possibility
external
stimulation.
The
aim
research
was
develop
new
type
bioactive,
chitosan-based
3D
materials
applicable
nerve
guide
conduits
(NGCs)
modified
poly(dopamine),
Au/Pt
coated
PVP
nanoparticles,
cannabidiol.
NGCs
prepared
under
microwave-assisted
conditions
their
chemical
studied
using
FT-IR
method.
Next,
study
will
discuss
novel
morphology
swelling
abilities
well
susceptibility
biodegradation
presence
collagenase
lysozyme.
Finally,
potential
field
has
been
via
cytotoxicity
1321N1
human
astrocytoma
cell
line,
which
confirmed
biocompatibility
direct
contact
studies.
Language: Английский
Advanced electrochemical detection methodologies for assessing neuroactive substance variability induced by environmental pollutants exposure
Yuanyuan Cao,
No information about this author
Chengkai Yang,
No information about this author
Chengshuai Liu
No information about this author
et al.
Environmental Technology & Innovation,
Journal Year:
2024,
Volume and Issue:
unknown, P. 103965 - 103965
Published: Dec. 1, 2024
Language: Английский
O uso terapêutico da Cannabis e seus derivados no tratamento de doenças neurodegenerativas
Lucas Soares Bezerra de Almeida,
No information about this author
Carolina Parentoni de Oliveira Brêttas,
No information about this author
Thaís Nacur Pimenta
No information about this author
et al.
Brazilian Journal of Health Review,
Journal Year:
2024,
Volume and Issue:
7(4), P. e71708 - e71708
Published: Aug. 6, 2024
Introdução:
Dentre
as
principais
DNs
pode-se
citar
a
Doença
de
Alzheimer,
Parkinson,
Coreia
Huntington,
Esclerose
Múltipla
e
Lateral
Amiotrófica,
todas
elas
progressivas
relacionadas
à
idade
fatores
risco
como
nutrição,
infecção,
stress
oxidativo
associadas
perda
e/ou
disfunção
neurônios
em
diferentes
regiões
do
encéfalo.
Assim,
com
milhões
pessoas
sendo
afetadas
declínio
cognitivo,
motora
outros
sinais
sintomas
neurológicos,
o
manejo
das
doenças
esboça
um
impacto
direto
no
bem-estar
dos
pacientes
seus
familiares,
constando
grande
fardo
social,
salutar
econômico,
uma
vez
que
exige
ampla
necessidade
cuidados
paliativos.
À
vista
disso,
diversos
estudos
foram
conduzidos
nas
últimas
décadas
acerca
uso
canabinóides
sua
relação
fitoterapia.
Objetivo:
Este
estudo
tem
objetivo
principal
realizar
análise
atuais
sobre
Cannabis
derivados
na
terapêutica
amplo
leque
neurodegenerativas,
fim
verificar
real
eficácia
nível
segurança.
Métodos:
Foi
realizada
busca
bases
dados
MEDLINE,
LILACS
SciELO.
Na
fase
identificação,
utilizando-se
os
descritores,
encontrados
76
artigos,
não
duplicados.
Sendo
assim,
tendo
base
critérios
inclusão,
filtrados
artigos
publicados
entre
Janeiro
2014
Julho
2024,
totalizando
66
artigos.
Ainda
elegibilidade,
verificando
tema
focal
da
pesquisa,
foi
excluído
1
artigo
estava
incompleto.
Ao
final,
selecionados
65
científicos
revisões
literatura
relatos
pesquisa.
Discussão:Apesar
promessas
terapêuticas
derivados,
pesquisa
aplicação
neurodegenerativas
ainda
enfrenta
várias
limitações
precisam
ser
abordadas
para
consolidar
seu
clínico.
Uma
preocupações
é
variabilidade
dosagem
formulação
produtos
utilizados
nos
estudos,
dificulta
comparação
direta
resultados.
Além
legislação
medicinal
varia
significativamente
países,
impactando
disponibilidade
aceitação
desses
tratamentos.
Ademais,
maioria
ensaios
clínicos
realizados
até
agora
apresenta
tamanhos
amostra
pequenos
períodos
acompanhamento
relativamente
curtos,
limita
capacidade
generalizar
achados
avaliar
efeitos
longo
prazo.
A
heterogeneidade
desenhos
populações
também
contribui
inconsistência
É
essencial
tratamentos
sejam
acompanhados
perto
por
profissionais
saúde
garantir
benefícios
superem
riscos,
crucial
continuar
investigação
entender
completamente
mecanismos
ação,
riscos
associados,
garantindo
baseados
evidências
robustas
seguras.
Conclusão:
Nota-se
mais
tema,
realização
bem
projetados
grandes
amostras
prazo,
validar
preliminares
fornecer
segurança
neurodegenerativas.
New Insights into the Development of Donepezil-Based Hybrid and Natural Molecules as Multi-Target Drug Agents for Alzheimer’s Disease Treatment
Molecules,
Journal Year:
2024,
Volume and Issue:
29(22), P. 5314 - 5314
Published: Nov. 11, 2024
Alzheimer's
disease
(AD)
involves
a
complex
pathophysiology
with
multiple
interconnected
subpathologies,
including
protein
aggregation,
impaired
neurotransmission,
oxidative
stress,
and
microglia-mediated
neuroinflammation.
Current
treatments,
which
generally
target
single
subpathology,
have
failed
to
modify
the
disease's
progression,
providing
only
temporary
symptom
relief.
Multi-target
drugs
(MTDs)
address
several
aggregation
of
pathological
proteins.
In
this
review,
we
cover
hybrid
molecules
published
between
2014
2024.
We
offer
an
overview
strategies
employed
in
drug
design
approaches
that
led
notable
improvements
reduced
hepatotoxicity.
Our
aim
is
insights
into
potential
development
new
drugs.
This
highlights
multi-target
featuring
heterocycles
Language: Английский